• Lexaria recently announced its intention to launch new human and animal studies exploring its patented DehydraTECH(TM) technology on GLP-1 drugs for the potential treatment of diabetes
• The studies will build on what Lexaria has achieved so far since it started its diabetes-related studies in 2022
• Its DehydraTECH-CBD demonstrated an almost three-fold improvement in drug delivery into the blood in its DIAB-A22-1 diabetes study compared to the DehydraTECH-CBD formulation used in its HYPER-H21-4 hypertension study
• These studies follow Lexaria’s announcement of its intention to study weight loss and diabetes control in a human population using DehydraTECH

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its intention to launch new human and animal studies that will explore its patented DehydraTECH(TM) technology on glucagon-like peptide-1 (“GLP-1”) drugs for improved bioavailability, cost-effectiveness, tolerability, weight loss potential, management of diabetes and other health conditions. Regarded as a significant expansion for Lexaria, these studies will build on what the company has achieved so far with its DehydraTECH-processed CBD while examining the technology’s impact on GLP-1 drugs (https://ibn.fm/r18NV).

The U.S. Food and Drug Administration (“FDA”) recently approved GLP-1 drugs for type 2 diabetes and weight loss management following their demonstration of an average loss of 15% of body weight across 667 individuals in a 68-week-long study. The drug has also demonstrated that some patients experience reduced cravings for alcohol, nicotine, and opioids while taking the drugs, with other trials showing the reduced build-up of proteins amyloid and tau in the brain, both thought to be partly responsible for Alzheimer’s.

Despite their overall potential, GLP-1 drugs have many side effects, ranging from mild ones, such as nausea and vomiting, to more serious ones, such as reduced bone density and muscle loss. Some of the more severe side effects have been reported when the drugs are taken in oral form, which has prompted researchers and medical practitioners to treat patients with lower oral doses. Given the overall nature of GLP-1 drugs to have low oral bioavailability, Lexaria, through its DehydraTECH technology, looks to address that, ultimately improving the drug’s pharmacokinetic (“PK”) performance.

In the recently completed DIAB-A22-1 diabetes study, Lexaria demonstrated an almost three-fold improvement in drug delivery into the blood compared to the DehydraTECH-CBD formulation used in its HYPER-H21-4 hypertension study. With such results in this and five other human clinical studies, Lexaria has proven severally that its technology can significantly improve the PK performance of many orally administered drugs into the bloodstream. Its applications have ranged from cannabinoids, estradiol, PDE-5 Inhibitors, and certain antiviral drugs. The company is optimistic about the technology’s application, GLP-1, and its potential to improve its bioavailability.

The animal and human clinical studies on GLP-1 will be a logical progression to Lexaria’s efforts to explore DehydraTECH in the potential treatment of diabetes, which kicked off in 2022. In its pre-clinical study DIAB-A22-1, DehydraTECH-CBD has yielded a 19.9% lowered blood glucose level, a 7% lowered overall body weight sustained over eight weeks, increased locomotor activity, lowered triglyceride levels by more than 25%, and lowered blood urea nitrogen levels by 27.9%. Given its intention to study weight loss and diabetes control in a human population using DehydraTECH, as announced on August 2, 2023, the GLP-1 studies come at the opportune time, facilitating this specific objective.

Program design for the GLP-1 study has already commenced, and initial study work is set to begin as soon as possible. This ambitious step affirms Lexaria’s commitment to creating shareholder value and advancing its technology to become a leader in its segment.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Appia recently entered into a definitive agreement to acquire up to a 70% interest in the 17,551.07-hectare PCH Project located in the State of Goiás, Brazil
• The company completed a due diligence program, with the initial results confirming widespread REE enrichment across the property
• Total rare earth element (“REE”) grades in numerous auger holes drilled at Target 4 ranged from 274 parts per million (“ppm”) to 16,648 ppm (1.66%), with an average of 1,291 ppm total REE, the results showed
• The PCH Project has a relatively higher content of heavy REE (“HREE”) in the deposit than Serra Verde, a large ionic-clay REE deposit and mine currently under construction in northern Goiás State
• Appia has since embarked on comprehensive exploration activities to uncover the potential of its highly promising deposit

Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF), a mineral exploration with multiple rare earths and uranium projects in mining-friendly jurisdictions, including Goiás State, Brazil and Saskatchewan and Ontario, Canada, took a “significant step in cementing itself among the upper tier of critical mineral explorers,” according to company President Stephen Burega, when it entered into a definitive agreement to acquire up to a 70% interest in the PCH Project (https://ibn.fm/cnyNm).

Located in the Tocantins Structural Province of the Brasilia Fold Belt, Goiás State, Brazil, the 17,551.07-hectare PCH Project is one of the few major ionic clay projects in the Western world and one of the relatively few ionic clay REE deposits found outside China. Ionic clays can be mined with low-cost open-pit mining technologies and processed using simple technologies, according to Burega (https://ibn.fm/ZX1UL), suggesting that the PCH Project will require low capital and operational expenditures.

The viability of the open pit mining system is supported by the fact that the project shows ionic clay development with elevated rare earth element (“REE”) values immediately below the surface and extending down to a depth of more than 15 meters, based on assay results obtained from the vendor of the high potential property (original assays).

Still, the company set out to confirm whether the original assay results represented the true composition and quality of the property, commencing a due diligence program in April this year. As part of the due diligence program, Appia completed 110 duplicate samples from twin augur holes staggered across Target 4 of the property and found comparable results to the original assays. The company also collected 17 samples from trenches and 76 samples from diamond drill holes, with the results comparable to the original results.

These initial results confirmed widespread REE mineralization in ionic clays deposited after weathering of alkaline granitic source rocks as well as in-situ REE enrichment linked to the area’s underlying granite complex and a carbonatite intrusion extending to depths of more than 100 meters (https://ibn.fm/5ak7t).

“Mineralization is widespread across the property, with the most advanced target being a 2 km wide zone in the southwestern corner of the tenements known as Target 4,” commented Don Hains, an expert in industrial minerals and a senior consulting geologist. “The exploration work by the vendor showed REE enrichment in the soils to depths of 8 to 26 m with the majority in the upper 8-10 meters. Total REE grades in numerous auger holes drilled at Target 4 ranged from 274 parts per million (“ppm”) to 16,648 ppm (1.66%), with an average of 1,291 ppm total REE and, importantly, the valuable rare earths used in magnet applications (Pr, Nd, Tb, and Dy) + Y accounted for approximately 14% of total rare earths, with a maximum of 28.4%.”

The initial results also showed that heavy REE (“HREE”) accounted for 13.93% of the total rare earths or 145 ppm. The company compared its results with data from the Serra Verde Project, a large ionic-clay REE deposit and mine currently at advanced stages of construction in the northern part of the Goiás State, noting that the PCH Project has a relatively higher content of HREE in the deposit than Serra Verde despite having lower total average REE values. “The Serra Verde project currently under construction in northern Goiás State has total average REE values of 2,138 ppm (0.2138%) but HREE values of only 155 ppm, or 7.26% of total rare earths,” explained Hains.

Encouraged, the company embarked on comprehensive exploration activities to uncover the potential of its highly promising deposit. So far, Appia’s exploration team has employed a strategic combination of cutting-edge LiDAR surveying, extensive auger sampling, and Reverse Circulation (“RC”) drilling. The company intends to use the data collected from these drill and survey programs to develop an initial mineral resource estimate (“MRE”) on Target 4 (https://ibn.fm/AxXI3).

For more information, visit the company’s website at www.AppiaREU.com.

NOTE TO INVESTORS: The latest news and updates relating to APAAF are available in the company’s newsroom at https://ibn.fm/APAAF

Serious investors — and anyone concerned with protecting and building wealth in volatile times — invited to attend the New Orleans Investment Conference to be held in New Orleans, November 1-4, 2023.

With a rich legacy spanning almost 50 years, the New Orleans Investment Conference has been acclaimed as “The Greatest Investment Show on Earth” by Money Magazine. Held in the heart of New Orleans, the 2023 Conference is set to present a dream team of world-class experts on geopolitics, macroeconomics and every asset class to hundreds of savvy investors.

The 2023 Conference will feature enlightening presentations from leading experts such as Konstantin Kisin, Matt Taibbi, Jim Rickards, Danielle DiMartino Booth, Lyn Alden, George Gammon, Rick Rule, Dominic Frisby, Brent Johnson, Dave Collum, Peter Boockvar, James Stack, Peter Schiff, Jim Iuorio, Tavi Costa, Adrian Day, Adam Taggart, The Real Estate Guys, Gwen Preston, Brent Cook, Brien Lundin, and many more. Early bird registration is still open, offering significant savings for those who secure their spots early.

To learn more, please visit https://ibn.fm/ISvQC

• GolfLync’s members embrace innovative features, including organizing tee times, sharing golf experiences, hosting events, and building lasting connections with like-minded enthusiasts
• The GolfLync app facilitates connections based on location and personal preferences on the course – making tee times more enjoyable and easier to facilitate
• The global golf club market is expected to grow at a CAGR of 2.5%, resulting in a value of $4.45 billion by 2027

GolfLync, one of the hottest and fastest-growing social networking platforms for golf enthusiasts, has announced that enrollment has surpassed 75,000 members across the United States. This monumental growth underscores the company’s mission and ability to unite golfers, creating dynamic golfing communities that continue to thrive. GolfLync’s revolutionary Virtual Golf Clubs(TM) (“VGCs”) have reshaped how golfers engage, share experiences, and bring together like-minded individuals to share experiences and the love of the sport (GolfLync Surpasses 75,000 Members Nationwide and Hosts Members in Over 700 Private and Public Virtual Golf Clubs(TM)).

From local golf clubs to large national networks, GolfLync members are embracing the platform’s abilities – featuring innovative features with private and public VCGs as the epicenter for organizing tee times, sharing golf experiences, hosting events, and building lasting connections. The enthusiasm and interaction of GolfLync’s members facilitate its ability to accomplish this remarkable growth.

GolfLync’s co-founder and CEO, Noah DiPasquale, shared his enthusiasm about the platform’s member growth and success: “The driving force behind GolfLync’s remarkable journey has been the genuine camaraderie and connection our members have found. It’s incredibly rewarding to see golfers from all walks of life come together, creating an online golfing community that is so vibrant and inclusive.”

GolfLync was created for golfers and enthusiasts of all skill levels to connect with compatible players of the same skill set. Through the company’s social networking application, members can connect and cultivate friendships, getting to know one another before committing to four hours on the course with a stranger. The GolfLync app allows users to find new golf friends based on their preferences, including walking or riding a cart, listening to music, friendly wagering, beverage preferences on the green, and more. Connections can also be made based on availability – if you need an additional person to fulfill your tee time, you can find them on the GolfLync app.

The global golf club market is expected to grow at a CAGR of 2.5%, resulting in a value of $4.45 billion by 2027. The market is driven by the growing popularity and adoption of golf as an active sport, with premium resorts and hotels incorporating golf into their sport and leisure offerings (https://ibn.fm/PfbcN). The popularity of the sport is being driven by the growing number of courses available in cities across the country – GolfLync is facilitating connections and allowing users to create their own golfing networks based on skill and preference. As more users join the GolfLync social networking platform, VCGs are expected to redefine the golfing revolution.

You can download the GolfLync app using the following links: Android: GolfLync – Apps on Google Play iPhone: GolfLync

For more information about GolfLync, visit GolfLync, download the app, and connect with community on Facebook, X and LinkedIn.

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

• SenesTech pioneered an innovative rat control method that restricts the fertility of both male and female rats, ContraPest(R)
• With cities around the country and the world, in general, implementing a raft of rat control methods, SenesTech is eager to work with city governments to address the rat crises
• Rat populations are surging in many major cities, driven by the post-COVID rebound in business and climate change
• Studies show that ContraPest can reduce rat populations by more than 90% and sustain the reduced numbers, when added to an integrated pest management plan

Once threatened by the sudden COVID-induced closure of businesses and restaurants, which forced rats to adapt by moving to residential areas in search of food or die – renowned rodentologist Bobby Corrigan estimates that hundreds of thousands, if not millions, died – the long-tailed rodents are now seemingly enjoying a change of fortune. Rat populations are surging in many major cities, driven by the post-COVID rebound in restaurant operations and the reopening of businesses, which are providing alternative and ample locations where the rodents find food. Moreover, “Climate change has brought longer stretches of warmer weather, which means more time for breeding,” explains an article in PBS (https://ibn.fm/Pqceu).

This is concerning. Rats cause billions of dollars in damages annually worldwide and carry harmful and sometimes deadly diseases. Thus, to avert a crisis, cities have moved to control the vermin, turning their attention toward addressing the trash problem as one of their many rat control initiatives. The Mayor of Washington, D.C., for instance, has allocated $3.4 million for the 2024 financial year to begin the replacement of residents’ trash bins with newer, larger cans.

On the other hand, New York City has changed the trash take-out times for residents and businesses to prevent garbage from sitting out for long, attracting rates. Additionally, the city has started mandating all food-related businesses to securely containerize food waste rather than disposing it in trash bags, with the New York City Mayor Eric Adams also hiring Kathleen Corradi as the new Director of Rodent Mitigation, the city’s first rat czar. New York City and Washington D.C. both rank among the rattiest cities in the country, according to pest control company Orkin, which ranks cities based on the number of new commercial and residential commercial treatments.

As cities continue to come up with and implement rat control initiatives, one company, SenesTech (NASDAQ: SNES), has turned to innovation, developing an innovative and unorthodox anti-rat method that many cities are adopting. SenesTech is looking to work with more cities as they seek to reduce rat populations. This April, company CEO Joel Fruendt attended New York’s Rodent Roundup and, together with SenesTech’s sales team, highlighted the importance of bringing ContraPest to New York City. “We are eager to help the new Rat Czar in addressing New York’s rat crisis in an effective and earth-friendly manner,” commented Fruendt (https://ibn.fm/17I4Q).

ContraPest(R) is a revolutionary technology that targets the reproductive capabilities of the roof and Norway rats, controlling their populations by restricting fertility in both males and females. SenesTech dubs ContraPest as the Birth Control for Rats(TM) and has, in fact, trademarked the tagline. Registered by the United States Environmental Protection Agency (“EPA”) in 2016, ContraPest was the first – and remains the only – rat contraceptive for male and female rats.

Not only is it designed to be humane, but it also does not bioaccumulate, meaning it does not travel up the food chain, affecting non-rat populations. SenesTech says the product is deliciously made with fats and sweets, attracting rats, which keep returning for more. This further boosts its effectiveness. ContraPest indeed works, according to the company. “When used as part of an integrated pest management (“IPM”) program, studies show it can reduce rat populations more than 90% and sustain the reduced numbers,” reads SenesTech’s website (https://ibn.fm/ZHZn7).

To further boost deployment, SenesTech launched a new delivery system for ContraPest, the Isolate Bait System(TM), earlier this year. The system boasts a simple design that enables more efficient deployment. It incorporates an enhanced formulation of ContraPest that is anticipated to offer enhanced performance of the fertility control bait in the field (https://ibn.fm/0d4tb). SenesTech is continuously working to provide effective solutions to the rat problem.

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

• Howard Weisman presented PaxMedica’s goals and plans to investors at the H.C. Wainwright 25th Annual Global Investment Conference on September 12, 2023
• The presentation defined the company’s intention to generate significant funding for its ASD program by first gaining approval for suramin sodium in the treatment of a rare and deadly infection using the same drug
• The global ASD treatment market was valued at $2.02 billion and is expected to reach $3.28 billion by 2030

Howard Weisman, CEO of PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurological symptoms, recently participated in the H.C. Wainwright 25th Annual Global Investment Conference on September 12, 2023. He presented the company’s presentation to investors, expressing the company’s overall goals and plans for its lead programs – PAX-101 and PAX-102. He also participated in one-on-one meetings with investors registered at the conference.

As expressed by Mr. Weisman in the company’s presentation, PaxMedica plans to develop a drug for autism using suramin sodium, which was created in the past to treat Human African Trypanosomiasis (“HAT”), a deadly form of sleeping sickness, but was discontinued. PaxMedica plans to use data from early drug testing as part of an application to treat rare cases of sleeping sickness, which occasionally infects Americans.

If the data is strong enough to persuade the FDA to approve suramin sodium for use in treating HAT, the company plans to commercialize PAX-101 initially for HAT treatment, potentially in partnership with a bigger pharmaceutical company. This early approval would then help substantially fund PaxMedica’s greater purpose, developing a novel treatment using suramin sodium as a treatment for ASD and Fragile X-Associated Tremor/Ataxia Syndrome (“FXTAS”).

According to Grand View Research, the global ASD treatment market was valued at $2.02 billion in 2022. By 2030, the market is expected to grow at a CAGR of 6.1%, resulting in a value of $3.28 billion. This growth is attributed to the number of novel treatments being tested and expected to be approved during the forecast period. There is an urgency among parents and caregivers of individuals with ASD for treatment – fueling the demand for the development of treatments (https://ibn.fm/PrgTA).

Current treatments on the market for ASD only address the symptoms of the condition, and no approved pharmacologic treatments target its cause or symptoms. APTs target the excess production of purines in cells. An overexpression of purines can offset homeostasis and result in an overproduction of cellular adenosine triphosphate, the main energy molecule in all living cells. PaxMedica is on a promising path to address the unmet medical needs of ASD, bringing hope to millions.

At this time, PaxMedica is the only public company focused on developing treatments for the core symptoms of ASD.

PaxMedica’s lead programs include:

• PAX-101 (IV Suramin) for ASD – PAX-101 completed a Phase 2B study for ASD in 2021. The results of PaxMedica’s Phase 2B study, which targeted 52 subjects across six sites in South Africa, were presented to AACAP in October 2021.
• PAX-102 (Intranasal Suramin) – PaxMedica has developed a proprietary intranasal suramin formulation.

PaxMedica’s presentation made special note that although initial data evaluation and associated FDA approval for suramin sodium for treating HAT should be completed within a few months, which will generate the necessary funding for research and development for an ASD drug, any final autism drug approval resulting from those trials will likely take a few years to complete.

For more information, visit the company’s website at www.PaxMedica.com.

NOTE TO INVESTORS: The latest news and updates relating to PXMD are available in the company’s newsroom at https://ibn.fm/PXMD

• SuperCom recently secured a new national program to deploy its Domestic Violence Monitoring Solution to the government of Finland
• Last year, Finland’s Parliament adopted the Finnish government’s proposal to enhance the effectiveness of the country’s law on restraining orders, resulting in a strengthened law that allows the court to order electronic monitoring of offenders
• SuperCom will deploy several innovative and proven technologies that are part of its PureSecurity EM Suite, including the PureProtect mobile phone application, PureTrack smartphone, PureTag ankle bracelet, and PureMonitor cloud-based monitoring software
• The new program follows a successful project with the Finnish government that saw SuperCom deploy its PureSecurity EM Suite to reduce prison overcrowding and lower recidivism

SuperCom (NASDAQ: SPCB), a leading provider of advanced safety, identification, and security products and solutions to governments as well as public and private organizations globally, recently announced it had secured a new national program to deploy its Domestic Violence Monitoring Solution to the government of Finland. The project aims to safeguard victims, proactively prevent domestic violence, and empower Finnish authorities with advanced technologies that enhance the safety and well-being of the country’s citizenry (https://ibn.fm/8i8Z1).

A part of SuperCom’s family of PureSecurity Electronic Monitoring (“EM”) products, the Domestic Violence Monitoring Solution includes several innovative and proven technologies: PureProtect mobile phone application, PureTrack smartphone, PureTag ankle bracelet, and PureMonitor cloud-based monitoring software.

At the center of the life-saving domestic violence solution is the PureProtect app installed on the victims’ smartphones or the PureTrack phone. PureProtect uses advanced zoning, proximity, alerting, and management capabilities to update victims on offenders’ whereabouts and send alerts upon prompt or whenever offenders move threateningly close to their victims (https://ibn.fm/gYkz3). The PureMonitor, on the other hand, is cloud-based monitoring software that law enforcement officers use to monitor offenders and manage the PureTag ankle bracelets worn by the offenders.

“We are delighted to secure another program for our innovative Domestic Violence Solution; this time in Finland. This achievement follows our successful deployment of other monitoring solutions for inmates and individuals on probation in Finland, and successful deployment of our domestic violence solution in other nations globally,” commented SuperCom CEO Ordan Trabelsi.

Finland introduced electronic ankle bracelets back in 2011 to track convicts, allowing them to serve short sentences at home instead of imprisonment (https://ibn.fm/r67uu). But for a long time since, the Nordic country applied electronic monitoring to offenders found repeatedly guilty of drunk driving and offenders who refused to do civilian or military service per their convictions. Little progress was made in adopting electronic tags to enforce restraining orders.

On its part, however, the Justice Ministry under the previous administration had long been mulling over the use of electronic monitoring and ankle monitors/tags to help safeguard victims of domestic violence, according to a 2019 article in YLE (https://ibn.fm/a5TAa). With the National Council of Women of Finland vocalizing the inadequacies of restraining orders in protecting victims of domestic violence, given that attackers could – and did – repeatedly violate the orders, EM was seen as a modern solution that helps prevent such violations.

To seal some of the loopholes in the prevailing regulations on restraining orders, which directly or indirectly facilitated the violations, the government last September submitted a proposal (HE 143/2022) to Parliament (https://ibn.fm/3sTN1). Finland’s Parliament adopted the proposal at the end of last year, and the resultant law, EV 203/2022, became effective October 1, 2023.

According to a Google translation of a section of the legislation, “At the request of an official entitled to arrest, the court may order that compliance with the extended restraining order is monitored by technical means, with technical devices placed in the possession of the restrained person or attached to the wrist, ankle, or waist… in order to combat the threat of a crime…” (https://ibn.fm/JrwCc).

SuperCom’s new national program with the government of Finland follows a successful $3.6 million project with the Finnish government. Launched earlier this year in March, the project saw SuperCom deploy its PureSecurity EM Suite, a best-of-breed EM and tracking platform, in Finland to help the country improve its public safety while reducing prison overcrowding and lower recidivism (https://ibn.fm/Fq777).

“Expanding our relationship with Finland through a new program within only a few short months from original project launch demonstrates the trust the nation’s Ministry of Justice places in SuperCom. This also acts as another testament to the undeniable effectiveness and reliability of our solutions,” continued Trabelsi.

According to Trabelsi, the new program underscores SuperCom’s dedication to providing cutting-edge security solutions to its customers and “marks yet another milestone in our commitment to creating safer communities around the world.”

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

• Dual ransomware attack trends are believed to have begun in early 2022, with two attacks occurring on the same business within a few hours of one another
• The FBI advises companies to implement migratory procedures and keep detailed, regular backups encrypted, as they are also often targeted
• Sekur offers a suite of services that include SekurMail, SekurVPN and SekurMessenger without relying on third-party cloud services and offering the highest level of encryption, with information stored in Switzerland

Dual ransomware attacks, where a gang attacks the same business twice within a few hours with ransomware, are being flagged by the FBI as a growing cybercrime trend that began in early 2022. They are warning that these attacks utilize two different strains of the same ransomware to inflict maximum damage, and can result in a combination of data encryption, exfiltration, and financial losses for the victims.

“Multiple ransomware groups increased use of custom data theft, wiper tools, and malware to pressure victims to negotiate,” the FBI warned. “In some cases, new code was added to known data theft tools to prevent detection.” To protect themselves from attacks, the FBI advises companies to implement migratory procedures and to keep detailed, regular backups that are encrypted – as backups are often targeted in subsequent attacks (https://ibn.fm/Dcfg6).

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0), a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure and private communications, distributes a privacy communications suite that offers encrypted and private email, the only Swiss-hosted privacy VPN, and a secure and private messaging application, catering to consumers, SMBs, enterprises, and governments. Unlike other competitors in the industry, Sekur owns 100% of its own infrastructure without relying on third-party cloud services like Amazon Web Services, Microsoft Azure Cloud, or Google Cloud infrastructure.

Sekur’s suite of services include:

• SekurMail – an encrypted email service offering a private, safe, and powerful tool to communicate with everyone, either within the Sekur ecosystem or outside. SekurMail protects personal information and communications from being accessed by unauthorized parties, with encryption and other security measures that prevent messages from being intercepted, modified, or tampered with.
• SekurVPN – creates a secure, encrypted connection between a client’s device and the internet, giving clients access to the web safely and privately by routing connections through a server and hiding online actions. All data sent and received is hidden from prying eyes, including Internet Service Providers, potential hackers, and government surveillance agencies.
• SekurMessenger – a Swiss-hosted private and secure messaging communications app providing secure and private chat, self-deleting chat, voice recording, and file transfer via any mobile device, tablet, or computer desktop using military-grade encryption to protect information sent. Communications are transmitted only within secure servers and are designed for organizations that need to protect their flow of information and secure their communications with customers and partners.

ReportLinker has estimated that the global cybersecurity market was valued at $173.5 billion in 2022. The market is expected to grow at a CAGR of 8.9%, resulting in a value of $266.2 billion by 2027. The market is being driven by the increased number of global data breaches, with malicious characters being able to operate from anywhere (https://ibn.fm/NhS7X).

With all the threats, including dual ransomware attacks, Sekur offers customers a confidential and safe way to store their information in Switzerland using military-grade security. All data, whether physical, network-based, or encryption security, is stored in bank-approved, state-of-the-art ISO-certified data centers used by Swiss and global banks and most UN organizations, corporations, and governmental organizations – the location is chosen because of the country’s neutrality, independence, strong privacy laws, long-standing political stability, and excellent international relations.

For more information, visit the company’s website at www.SekurPrivateData.com or the company’s product website at www.Sekur.com.

NOTE TO INVESTORS: The latest news and updates relating to SWISF are available in the company’s newsroom at https://ibn.fm/SWISF

Large, mid-size, and small pharma companies, are invited to attend the 18th Biopharma Drug Discovery Nexus being held October 17-18, 2023, in Philadelphia. As the countdown for this prestigious event begins, the world is set to witness the innovative benchmarks in the realm of life sciences and drug discovery. The 18th edition of this event will serve as an incredible platform for advanced technologies, groundbreaking research, and collaborative discussions.

The BioPharma Drug Discovery Nexus has long been synonymous with technological advancement in the life sciences industry. The popular event will bring together specialists and thought leaders from across the pharmaceutical and biotechnology sectors. Attendees have a great opportunity to meet important industry pioneers and explore the cutting-edge innovations that are redefining the industry’s growth.

Promoting BioPharma Innovation and Discovery

The 18th BioPharma Drug Discovery Nexus will feature a legion of industry experts who will showcase their expertise on different critical topics such as precision medicine, drug repurposing, AI-driven drug discovery, and much more. The professionals will share valuable insights into the latest industry offerings, services, and solutions.

Building meaningful connections is a hallmark of the BioPharma Drug Discovery Nexus. From budding biotech entrepreneurs to veteran pharmaceutical experts, this event is designed to cater to a wide range of specialists. Participants will get ample networking opportunities to collaborate with potential partners and advisors. They can join expert-led sessions and meetings to gain fresh insights into the ever-growing life sciences and drug discovery industries.

To learn more, please visit https://nnw.fm/vVCL6.

• Electronic Servitor Publication Network, helping B2B companies use smart technology to reach target markets, is focused on eliminating wastefulness, driving growth, and spawning modern businesses that can navigate the ever-evolving digital world
• The company has developed the revolutionary Digital Engagement Engine(TM), which combines cutting-edge data analysis, a technology stack that can identify even the narrowest of niches within a target market, tailored content, and precision delivery
• The platform expands and creates increased reach to new communities and preserves existing reach by nurturing audiences and creating genuine interest
• The Digital Engagement Engine(TM) and other smart technologies are shaping the future of content marketing

Artificial intelligence (“AI”) can help marketers accelerate and optimize written content creation, presenting improved ways of driving engagement, reaching readers in the most efficient modes possible, building authority in their respective industries, and guiding consumers through the purchasing process. According to an Insider Intelligence report, “AI can assist with the planning stage of content production using tools that dynamically cluster relevant content topic to help markers identify actionable opportunities” (https://ibn.fm/54GbF).

Leading marketers are also capitalizing on the power of smart technologies to help them maintain a consistent tone and writing style, accelerate the writing process by generating content briefs or outlines, and create regular, quality content. It’s important to remember that AI is just one of many smart technologies shaping the future of content marketing; other technologies are playing an equally important role in supporting the work of marketers. One such technology is the Digital Engagement Engine(TM), the brainchild of Electronic Servitor Publication Network (OTCQB: XESP), a company looking to disrupt the market for B2B companies by driving better digital interactions that enable better results.

In observing today’s saturated markets, XESP identified the inefficiencies of simple omnichannel marketing and trendy guerilla marketing strategies, noting their inability to generate enough traction and noise within digitally connected communities. “Have you been getting the results from the tools and technologies that are out there today, and are you satisfied with that?” XESP CEO Peter Hager asked in an interview with The Spotlight Network (https://ibn.fm/EM0Ge). “Our answer is no; the answer of the people we interact with is no, and they are demanding [for] more.”

On its part, Electronic Servitor Publication Network has embraced the challenge and is out to fill the market gap and effectively meet the demand for more. The company focuses on eliminating wastefulness, driving growth, and spawning modern businesses that can navigate the ever-evolving digital space, thus increasing digital interactions with new and existing communities. Central to the success of its plans is its revolutionary Digital Engagement Engine(TM).

“With our Digital Engagement Engine(TM), it’s not just about throwing everything you’ve got against the wall and hoping something sticks,” says the company. Instead, the company’s advanced platform combines cutting-edge data analysis, a technology stack that can identify even the narrowest of niches within a target market, tailored content, and precision delivery to create a “laser-focused approach that makes every customer feel like you’re talking directly to them.”

Marketers and businesses that partner with XESP have their work cut out for them. Marketing teams have to constantly manage and optimize their content to stay relevant. But often, content management and optimization take up a lot of time and can be confusing even for the most experienced providers. However, partnering with Electronic Servitor Publication Network makes this process far smoother.

XESP uses its Digital Engagement Engine(TM), built on workflows and a microservices architecture that automates tasks needed to make digital connections, to more easily provision, manage, and monetize content. In doing so, the platform expands and creates increased reach to new communities and preserves existing reach by nurturing audiences and creating genuine interest, thus boosting the visibility of brands. Put simply, Electronic Servitor Publication Network is reinventing how companies digitally connect with people.

For more information, visit the company’s website at www.XESPN.com.

NOTE TO INVESTORS: The latest news and updates relating to XESP are available in the company’s newsroom at https://ibn.fm/XESP